Adaptive Biotechnologies Corp (ADPT) support and resistance · rev $142.4M
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
This page maps Adaptive Biotechnologies Corp (ADPT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
ADPT currently screens at market cap $2.69B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ADPT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ADPT quote page for the session range and the stock page for the full model.
Not investment advice.